Atabak Mokari

Insider Reports History

Entity
Individual
Location
1212 Terra Bella Avenue, Mountain View, CA
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Atabak Mokari.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atabak Mokari:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CORCEPT THERAPEUTICS INC Chief Financial Officer Common Stock 12.8K $758K $59.21 Dec 2, 2024 Direct
CORCEPT THERAPEUTICS INC Chief Financial Officer Stock option (right to buy) 200K Feb 9, 2024 Direct

Insider Reports Filed by Atabak Mokari

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CORT CORCEPT THERAPEUTICS INC Dec 2, 2024 3 $3.18K 4 Dec 4, 2024 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Sep 3, 2024 3 $8.66K 4 Sep 5, 2024 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Jun 3, 2024 3 $28.1K 4 Jun 5, 2024 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Mar 1, 2024 3 $890 4 Mar 5, 2024 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Feb 9, 2024 1 $0 4 Feb 13, 2024 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Dec 1, 2023 2 $13.2K 4 Dec 5, 2023 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Sep 1, 2023 2 $13.2K 4 Sep 6, 2023 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Jun 1, 2023 2 $37.9K 4 Jun 5, 2023 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Mar 1, 2023 2 $25K 4 Mar 3, 2023 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Sep 1, 2022 2 $20.6K 4 Sep 6, 2022 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Feb 13, 2022 1 $0 4 Feb 15, 2023 Chief Financial Officer
CORT CORCEPT THERAPEUTICS INC Feb 2, 2022 1 $0 4 Feb 11, 2022 Chief Financial Officer